Psychedelics: A New Look at Mental Health
Exploring psychedelics’ potential in treating mental health disorders and ego dissolution.
Clayton R. Coleman, Kenneth Shinozuka, Robert Tromm, Ottavia Dipasquale, Mendel Kaelen, Leor Roseman, Suresh Muthukumaraswamy, David J. Nutt, Lionel Barnett, Robin Carhart-Harris
― 6 min read
Table of Contents
Psychedelics are a group of substances that can cause changes in perception, mood, and thought. They have been used for many years across different cultures, often in spiritual or healing contexts. Recently, scientists have begun to explore their potential for treating mental health issues, such as depression, anxiety, and addiction. Some of the most well-known psychedelics include LSD and psilocybin, which is found in certain mushrooms.
Over the last decade, there has been a resurgence in research on these substances, leading to new clinical trials. These studies suggest that psychedelics might help people who are struggling with psychiatric disorders. For instance, psilocybin has shown promise in helping those facing end-of-life distress, quitting smoking, and dealing with major depression. On the other hand, LSD has produced positive outcomes for generalized anxiety and major depressive disorder in clinical trials.
Other Treatments for Mental Health
While psychedelics are making headlines, there are other established methods to treat mental health problems. One such method is Transcranial Magnetic Stimulation (TMS), a non-invasive therapy that uses magnetic fields to stimulate nerve cells in the brain. One specific type called Theta Burst Stimulation (iTBS) has shown about a 90% success rate in treating major depressive disorder. This technique targets a part of the brain known as the left dorsolateral prefrontal cortex (lDLPFC), which is important for managing mood.
Another version of TMS, known as rTMS, has been found to help reduce symptoms of mania when combined with medication. This approach is now considered a third-line treatment option for mania in Canada. Different frequencies of TMS can either excite or inhibit brain activity in specific areas, showing a lateralization of function, meaning different sides of the brain have particular roles in regulating mood and emotional responses.
Ego Dissolution
The Experience ofOne fascinating aspect of psychedelics is the experience of ego dissolution, which can drastically alter one’s mood. This experience often involves feeling connected to everything around you, where the distinction between self and others becomes blurred. Some people find it uplifting and euphoric, while others may feel anxious. The emotional charge during psychedelic experiences can resemble symptoms of mania or even psychosis, particularly in people with conditions like bipolar disorder or schizophrenia, who often have trouble regulating their emotions.
The way a person experiences Emotional Arousal on psychedelics can be measured and understood through questionnaires designed to assess altered states of consciousness. These measures can offer insights into how psychedelics affect emotional states and the sense of self.
The Research Study
In an effort to better understand how psychedelics affect the brain and the experience of ego dissolution, researchers conducted a study with healthy volunteers. Participants received both LSD and a placebo in separate sessions while their brain activity was monitored using advanced imaging techniques. After each session, they filled out a questionnaire to report their feelings, including mood, ego dissolution, and emotional arousal.
The researchers aimed to find connections between these subjective experiences and the brain's functional connectivity. They specifically looked at the left and right DlPFC, two important regions most commonly associated with mood regulation. The hypothesis was that LSD would change the connectivity of these areas, which would correlate with reported changes in mood and ego dissolution.
Data Collection and Analysis
Brain data was collected utilizing various imaging techniques, such as functional magnetic resonance imaging (fMRI) and magnetoencephalography (MEG). While the study focused primarily on fMRI data to assess resting-state brain activity, the MEG data provided information about the timing of brain connectivity.
Participants underwent two different scanning sessions, one while they were under the influence of LSD and the other while they received a placebo. After the sessions, they completed a Visual Analogue Scale questionnaire with six domains related to their subjective experience.
Data collection involved careful preprocessing to ensure that the results were accurate and reliable. This included removing any irrelevant data caused by movement and various nuisance factors, leaving a dataset suitable for analysis.
The Findings: How the Brain Connects
The study’s analysis found that LSD significantly increased the functional connectivity between the DLPFC and parts of the Default Mode Network (DMN), a brain network involved in self-referential thoughts and mind-wandering. This suggests psychedelics might create a framework for more interconnected brain activity, leading to novel experiences and perceptions.
Interestingly, the research discovered that ego dissolution was significantly connected with particular brain regions. Increased connectivity was found between the DLPFC and areas like the thalamus and fusiform gyrus. These findings confirm that ego dissolution might involve complex brain networks rather than isolated regions.
Furthermore, emotional arousal correlated with activity in the right DLPFC, indicating that this area may play a significant role in processing emotional responses during psychedelic experiences.
The Role of Granger Causality
In addition to examining functional connectivity, researchers also used Granger Causality analysis to assess directed connections between brain regions. This analysis allows scientists to see if activity in one brain region can predict activity in another over time.
The results showed that LSD increased the directed connectivity from the thalamus to the right DLPFC and from the inferior frontal gyrus to the right DLPFC in specific frequency bands. This indicates that psychedelics may influence how information flows through the brain, suggesting a more dynamic interaction among different regions.
Understanding the Lateralization of DLPFC Functions
Overall, the findings illuminate the different roles of the left and right DLPFC in mood regulation and emotional response. The left DLPFC is often associated with reducing depressive symptoms, while the right DLPFC might be more involved in managing mania. The study’s results align with the idea that ego dissolution engages both sides of the DLPFC, as it relates to both emotional arousal and the sense of self.
Importantly, the ability of psychedelics to blur the lines of self-identity and emotional experience could have therapeutic implications. If ego dissolution helps alleviate symptoms of depression, it may be beneficial for the treatment process, allowing individuals to step outside their usual limitations and explore new possibilities.
Final Thoughts: The Potential of Psychedelics
The increased interest in psychedelics and their effects on the brain signifies a shift in the way we understand mental health treatments. While traditional therapies focus on symptom management, psychedelics may offer a more profound approach by allowing individuals to see beyond their self-imposed boundaries.
As we continue to explore the complex connections in the brain during psychedelic experiences, we may find new ways to help people struggling with mental health issues. Perhaps one day, with the right guidance and understanding, these intriguing substances could help reshape our understanding of ‘self’ and expand our emotional landscapes.
So, while perhaps not everyone is ready to take a trip on a psychedelic rollercoaster, it’s clear that these substances hold promise worth investigating, adding new colors to the paints we use to paint the complex portrait of the human mind.
Original Source
Title: The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State
Abstract: Lysergic acid diethylamide (LSD) is a classic serotonergic psychedelic that induces a profoundly altered conscious state. In conjunction with psychological support, it is currently being explored as a treatment for generalized anxiety disorder and depression. The dorsolateral prefrontal cortex (DLPFC) is a brain region that is known to be involved in mood regulation and disorders; hypofunction in the left DLPFC is associated with depression. This study investigated the role of the DLPFC in the psycho-emotional effects of LSD with functional magnetic resonance imaging (fMRI) and magnetoencephalography (MEG) data of healthy human participants during the acute LSD experience. In the fMRI data, we measured the correlation between changes in resting-state functional connectivity (RSFC) of the DLPFC and post-scan subjective ratings of positive mood, emotional arousal, and ego dissolution. We found significant, positive correlations between ego dissolution and functional connectivity between the left & right DLPFC, thalamus, and a higher-order visual area, the fusiform face area (FFA). Additionally, emotional arousal was significantly associated with increased connectivity between the right DLPFC, intraparietal sulcus (IPS), and the salience network (SN). A confirmational "reverse" analysis, in which the outputs of the original RSFC analysis were used as input seeds, substantiated the role of the right DLPFC and the aforementioned regions in both ego dissolution and emotional arousal. Subsequently, we measured the effects of LSD on directed functional connectivity in MEG data that was source-localized to the input and output regions of both the original and reverse analyses. The Granger causality (GC) analysis revealed that LSD increased information flow between two nodes of the ego dissolution network, the thalamus and the DLPFC, in the theta band, substantiating the hypothesis that disruptions in thalamic gating underlie the experience of ego dissolution. Overall, this multimodal study elucidates a role for the DLPFC in LSD-induced states of consciousness and sheds more light on the brain basis of ego dissolution.
Authors: Clayton R. Coleman, Kenneth Shinozuka, Robert Tromm, Ottavia Dipasquale, Mendel Kaelen, Leor Roseman, Suresh Muthukumaraswamy, David J. Nutt, Lionel Barnett, Robin Carhart-Harris
Last Update: 2024-12-15 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.09.627609
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.09.627609.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.